hrs4r
Quiero donar
Firma
RAMON NOVELL-ALSINA
Posición
Investigador/a Consolidat - R3
Investigador/a Consolidado - R3

Projectes

Codi oficial: 101049115 Data inicio:01/03/2022 Data fi: 31/08/2024 Investigador/a principal: RAMON NOVELL ALSINA, LAURA VERGES PLANAGUMA Organisme finançador: EUROPEAN COMISSION

Publicacions

Rodríguez-Hidalgo E, García-Alba J, Novell R, Esteba-Castillo S

The Global Deterioration Scale for Down Syndrome Population (GDS-DS): A Rating Scale to Assess the Progression of Alzheimer's Disease.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20065096
Esteba-Castillo S, Garcia-Alba J, Rodríguez-Hildago E, Vaquero L, Novell R, Moldenhauer F, Castellanos MÁ

Proposed diagnostic criteria for mild cognitive impairment in Down syndrome population

JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2022, 35, 495-505 dx.doi.org/10.1111/jar.12959
Rodríguez-Hidalgo E, García-Alba J, Buxó M, Novell R, Esteba-Castillo S

The Pictorial Screening Memory Test (P-MIS) for Adults with Moderate Intellectual Disability and Alzheimer's Disease

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph191710780
Caixàs A, Blanco-Hinojo L, Pujol J, Deus J, Giménez-Palop O, Torrents-Rodas D, Coronas R, Novell R, Esteba-Castillo S

Altered Gesture Imitation and Brain Anatomy in Adult Prader-Willi Syndrome Patients

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2021, 27, 1024-1036 dx.doi.org/10.1017/S1355617721000060
Cobo J, Coronas R, Pousa E, Oliva JC, Giménez-Palop O, Esteba-Castillo S, Novell R, Palao DJ, Caixàs A

Multidimensional Evaluation of Awareness in Prader-Willi Syndrome

Journal of Clinical Medicine, 2021, 10 dx.doi.org/10.3390/jcm10092007
de la Torre R, de Sola S, Farré M, Xicota L, Cuenca-Royo A, Rodriguez J, León A, Langohr K, Gomis-González M, Hernandez G, Esteba S, Del Hoyo L, Sánchez-Gutiérrez J, Cortés MJ, Ozaita A, Espadaler JM, Novell R, Martínez-Leal R, Milá M, Dierssen M

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

CLINICAL NUTRITION, 2020, 39, 378-387 dx.doi.org/10.1016/j.clnu.2019.02.028
Novell R, Esteba-Castillo S, Rodriguez E

Efficacy and safety of a GABAergic drug (Gamalate® B6): effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHD.

Drugs in Context, 2020, 9, 212601-212601 dx.doi.org/10.7573/dic.212601
Martínez-Leal R, Folch A, Munir K, Novell R, Salvador-Carulla L, Borderline Intellectual Functioning Consensus Group

The Girona declaration on borderline intellectual functioning

LANCET PSYCHIATRY, 2020, 7, 8-8 dx.doi.org/10.1016/S2215-0366(20)30001-8
Hassiotis A, Brown E, Harris J, Helm D, Munir K, Salvador-Carulla L, Bertelli M, Baghdadli A, Wieland J, Novell-Alsina R, Cid J, Vergés L, Martínez-Leal R, Mutluer T, Ismayilov F, Emerson E

Association of Borderline Intellectual Functioning and Adverse Childhood Experience with adult psychiatric morbidity. Findings from a British birth cohort

Bmc Psychiatry, 2019, 19, 387-387 dx.doi.org/10.1186/s12888-019-2376-0
García-Alba J, Ramírez-Toraño F, Esteba-Castillo S, Bruña R, Moldenhauer F, Novell R, Romero-Medina V, Maestú F, Fernández A

Neuropsychological and neurophysiological characterization of mild cognitive impairment and Alzheimer's disease in Down syndrome

NEUROBIOLOGY OF AGING, 2019, 84, 70-79 dx.doi.org/10.1016/j.neurobiolaging.2019.07.017

Formulari de contacte

Conoce el IDIBGI!

menu